Company profile: uMotif
1.1 - Company Overview
Company description
- Provider of a scalable, engaging, patient-centred data capture platform for modern clinical research, enabling compliant, validated e-consent, eCOA, ePRO, PROM and PREM. Delivers configurable patient engagement, study-specific eDiaries on mobile and web, complex ClinROs with audio upload, telehealth for onboarding and consent, and integration with devices, sensors and third-party systems.
Products and services
- Devices and Wearables Integration: Study-specific integrations that unify data from devices, sensors, and third-party systems on a study-by-study basis, supporting scalable patient-centred capture for modern research
- ECOA/ePRO Platform: Cloud-based system capturing eCOA and ePRO across clinical trials and real-world studies, with patient-centred data entry and structured PROM and PREM capture for researchers and clinicians
- EConsent and Telehealth: Validated onboarding and remote consent system enabling informed e-consent capture and telehealth interactions, enhancing participant experience with patient-facing workflows tailored to clinical research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to uMotif
Trier Health
HQ: United States
Website
- Description: Provider of a smart, trusted and secure platform for digital clinical trial execution, supporting hybrid and 100% decentralized trials, enriching patient-clinician collaboration and patient engagement through analytics and deep AI, featuring VISION Recruit for AI-driven participant matching, outreach and scheduling, and VISION Engage for patient self-screening, self-scheduling, payments and profile management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trier Health company profile →
Cypher Genomics
HQ: United States
Website
- Description: Provider of automated human genome interpretation software for next-generation sequencing, supporting diagnostics development and biomarker analysis for clinical labs, pharmaceutical companies, and population genomics efforts; offers the Mantis Genomic Coral Biomarker Array Chip, qPCR Assay, and miscellaneous diagnostic ELISA kits. Platform allows clinical labs to tune sensitivity and specificity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cypher Genomics company profile →
Notocord
HQ: France
Website
- Description: Provider of life sciences software for data acquisition, analysis and reporting in experimental drug research, with solutions for cardiovascular, respiratory and electrophysiology signal analysis in Safety Pharmacology, Toxicology, R&D, academic and preclinical research, including NOTOCORD-hem Evolution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Notocord company profile →
Warp Drive Bio
HQ: United States
Website
- Description: Provider of a proprietary genomic search engine and customized search queries that reveal hidden natural products on the basis of their distinctive genomic signature.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Warp Drive Bio company profile →
Infonetica
HQ: United Kingdom
Website
- Description: Provider of intuitive software and solutions enabling end-to-end research management, including Research Flow for project lifecycle, Ethics RM for ethics applications and compliance, ReDA for clinical trial management, Pre-award for grant proposals, Contracts for research partnerships, and DPIA for data protection impact assessments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infonetica company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for uMotif
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to uMotif
2.2 - Growth funds investing in similar companies to uMotif
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for uMotif
4.2 - Public trading comparable groups for uMotif
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →